Study on the Protective Effects of Jigucao Capsule in Rat Liver Fibrosis
|更新时间:2024-01-04
|
Study on the Protective Effects of Jigucao Capsule in Rat Liver Fibrosis
Chinese Journal of Experimental Traditional Medical FormulaeVol. 15, Issue 10, Pages: 99-101(2009)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2009
稿件说明:
移动端阅览
ZHAO Ping1, YE Zhi-wen1, HE Dan-xuan1, et al. Study on the Protective Effects of Jigucao Capsule in Rat Liver Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2009, 15(10): 99-101.
DOI:
ZHAO Ping1, YE Zhi-wen1, HE Dan-xuan1, et al. Study on the Protective Effects of Jigucao Capsule in Rat Liver Fibrosis[J]. Chinese journal of experimental traditional medical formulae, 2009, 15(10): 99-101.DOI:
Study on the Protective Effects of Jigucao Capsule in Rat Liver Fibrosis
Objective:To research the influence of Jigucao Capsule to rat liver fibrosis
to provide a experimental basis for the expansion of clinical indications.Methods:Rat liver fibrosis model by 40% CCl4(v/v)subcutaneous injection was built up
and intervented with different concentrations of Jigucao Capsule suspensionorally.Results:Jigucao Capsule could improve the liver function of model rat
and increase serum TP
ALB.It could improve the rat serum antioxidant indicators
increase serum SOD content
and reduce the MDA content.It could reduce the pathological changes of the liver damage to show a lower value of liver fibrosis.Conclusion:Jigucao Capsule showed apparent protective effect to rat with liver fibrosis.It could significantly reduce the degree of liver fibrosis.
Protective Effect of Extracts from Astragali Radix on Liver Fibrosis Induced by CCl in Rats
Mechanism and Combination Therapy of Berberine in Treatment of Nonalcoholic Fatty liver Disease:A Review
Clinical Efficacy of Gandou Fumu Granules in Intervention of Liver Fibrosis in WD Patients with Phlegm and Blood Stasis Syndrome and Effect on Cuproptosis-related Indicators
Gandouling Regulates PI3K/Akt/mTOR Autophagy Signaling Pathway via LncRNA H19 for Treatment of Wilson Disease Liver Fibrosis
Mechanism of Shugan Huazheng Prescription Against Liver Fibrosis Based on HIF-1α/VEGF/TGF-β1 Pathway
Related Author
LI Cheng-hao
ZHANG Hong-ying
WANG Xiaojie
ZHANG Heng
LIU Sutong
ZHANG Lihui
ZHAO Wenxia
WANG Fei
Related Institution
The First Affiliated Hospital of Henan University of Chinese Medicine
The First Clinical Medical College of Henan University of Chinese Medicine
Henan General Hospital
Graduate School of Anhui University of Chinese Medicine
The First Affiliated Hospital of Anhui University of Chinese Medicine